Market Access Lead – Oncology

GSK remains committed to achieving bold commercial ambitions for the future. By 2031, we aim to deliver £40 billion in annual sales, leveraging our existing strong performance momentum to significantly increase our positive impact on the health of billions of patients globally. Our Ahead Together strategy is centred on early intervention to prevent and alter the course of disease, thereby protecting people and supporting healthcare systems. Our diverse portfolio consists of vaccines, specialty medicines, and general medicines. Through continuous innovation and a dedicated focus on scientific and technical excellence, we strive to develop and launch new, groundbreaking treatments that address critical health challenges. Job purpose Lead market access strategy and execution for the Oncology and Hematology portfolio in Egypt, securing and sustaining optimal patient access, pricing and reimbursement in alignment with global, regional and local priorities. Partner with Commercial, Medical, CGA, Finance, Regulatory and Global/Regional Market Access to shape the access environment for oncology and hematology medicines. Key accountabilities Access Strategy and Planning ·  Lead the Oncology and Hematology Market Access Managers. ·  Develop and implement integrated access strategies for oncology and hematology brands and pipeline assets, covering pricing, reimbursement, funding, tendering and HTA/value dossiers. ·  Translate brand and portfolio strategies into access objectives, milestones and KPIs. ·  Provide local access and policy insights into global/regional strategies and lifecycle plans. Pricing, Reimbursement and Tenders ·  Support pricing strategies for the oncology and hematology portfolio, aligned with GSK policies, local regulations and reference pricing requirements. ·  Lead or support payer, authority and institutional negotiations on reimbursement, funding, tenders and contracts. ·  Lead Access Managers in assessing pricing and reimbursement impacts on access and business performance. Stakeholder Engagement and CGA Interface ·  Map and manage relationships with MoH, reimbursement bodies, KOLs, professional societies, patient organisations and payers relevant to oncology and hematology, aligned with Ethics & Compliance. ·  Partner with CGA on policy-shaping and advocacy to improve oncology and hematology patient access. ·  Ensure compliant, non-promotional engagement where required, aligned with GSK standards and local codes. Evidence, Value and Insight Generation ·  Partner with HEOR and Medical on local value propositions for oncology and hematology, including RWE, economic models, burden of disease and patient outcomes. ·  Contribute access/reimbursement dossiers, presentations and payer/authority materials. ·  Monitor time to reimbursement, coverage, funding, tender win rates and patient access metrics; propose corrective actions. Cross-Functional Collaboration and Governance ·  Act as the oncology and hematology access lead in brand teams and launch-readiness forums. ·  Collaborate with Commercial, Medical, Finance, Regulatory, Legal and Supply Chain on integrated planning and execution. ·  Provide access training and guidance on pricing, reimbursement, policy and access topics. Required qualifications and experience ·  University degree in pharmacy, medicine, health economics, public health, economics or a related field; a postgraduate qualification is preferred. ·  5+ years of experience in market access, health economics, pricing, policy or related pharmaceutical/healthcare roles. ·  Experience in oncology and/or hematology is strongly preferred. ·  Solid understanding of Egyptian healthcare, reimbursement and policy environments, including MoH, public payers, private insurers and tenders, and strong track recor